- Effective management of pulmonary arterial hypertension (PAH).
- Improves exercise capacity and quality of life in patients with PAH.
- Reduces pulmonary vascular resistance through vasodilation.
- Can be used in combination with other PAH therapies for enhanced efficacy.
- Helps alleviate symptoms associated with PAH, such as shortness of breath and fatigue.
- May contribute to improved hemodynamic parameters in patients.
- Supports long-term management strategies for chronic pulmonary conditions.
Verquvo 5 mg Tablet - Strip of 14
Compositions : Vericiguat 5mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Bayer Pharmceuticals Pvt Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Verquvo 5 mg Tablet is a prescription medication primarily used in the management of pulmonary arterial hypertension (PAH). This condition is characterized by high blood pressure in the arteries that supply the lungs, leading to various complications and reduced quality of life. The active ingredient in Verquvo 5 mg Tablet is vericiguat, which belongs to a class of medications known as soluble guanylate cyclase (sGC) stimulators. By enhancing the sensitivity of sGC to nitric oxide, Verquvo 5 mg Tablet promotes vasodilation, thereby reducing pulmonary vascular resistance and improving exercise capacity in patients with PAH. The formulation is designed for oral administration, allowing for convenient dosing. Verquvo 5 mg Tablet is typically prescribed as part of a comprehensive treatment plan that may include other medications and lifestyle modifications aimed at managing PAH effectively. It is essential for patients to adhere to their prescribed regimen and consult healthcare professionals for any concerns regarding their treatment with Verquvo 5 mg Tablet. This medication has been shown to improve symptoms and overall functional capacity in individuals suffering from this debilitating condition, making it a vital component in the therapeutic arsenal against pulmonary arterial hypertension.
Product Details
- Verquvo 5 mg Tablet stimulates soluble guanylate cyclase (sGC), enhancing its sensitivity to nitric oxide.
- This action leads to increased levels of cyclic guanosine monophosphate (cGMP), promoting relaxation of vascular smooth muscle.
- The resultant vasodilation decreases pulmonary arterial pressure.
- Improved blood flow reduces the workload on the heart.
- Enhances oxygen delivery to tissues, improving overall exercise capacity.
- Take Verquvo 5 mg Tablet orally, with or without food.
- The usual starting dose is 2.5 mg once daily, which may be increased to 5 mg based on tolerance and clinical response.
- Administer at the same time each day to maintain consistent blood levels.
- Do not crush or chew the tablet; swallow it whole with water.
- If a dose is missed, take it as soon as remembered unless it's close to the next scheduled dose; do not double up.
- Consult your healthcare provider for personalized dosage adjustments based on individual health status.
- Regular follow-up appointments are essential to monitor treatment efficacy and side effects.
- Maintain a balanced diet rich in fruits, vegetables, and whole grains to support overall cardiovascular health.
- Engage in regular physical activity as advised by your healthcare provider to improve exercise tolerance.
- Avoid smoking and limit alcohol consumption, as these can exacerbate PAH symptoms.
- Stay hydrated and manage stress through relaxation techniques such as yoga or meditation.
- Monitor your weight regularly and report any significant changes to your healthcare provider.
Safety Advice
Side Effects
- Common side effects may include headache, dizziness, nausea, and fatigue.
- Some patients may experience low blood pressure, leading to symptoms like fainting or lightheadedness.
- Serious side effects can include allergic reactions, chest pain, or signs of liver problems such as jaundice.
- If you notice any unusual symptoms or side effects that persist or worsen, contact your healthcare provider promptly.
- Regular monitoring by your healthcare provider is recommended to ensure safety during treatment with Verquvo 5 mg Tablet.
Precautions and Warnings
- Do not use Verquvo 5 mg Tablet if you are allergic to vericiguat or any of its components.
- Patients with severe liver or kidney impairment should use this medication cautiously and under strict medical supervision.
- Avoid using Verquvo 5 mg Tablet in combination with nitrates or other sGC stimulators due to the risk of hypotension.
- Alcohol consumption should be limited while taking this medication due to potential interactions affecting blood pressure.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using this medication.
- Driving or operating heavy machinery may be unsafe if you experience dizziness or fatigue while taking Verquvo 5 mg Tablet; exercise caution.
FAQs
Verquvo 5 mg Tablet may not be suitable for individuals with certain medical conditions or those taking specific medications. Always consult your healthcare provider before starting this medication.
2. What should I do if I miss a dose of Verquvo 5 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
3. Can I drink alcohol while taking Verquvo 5 mg Tablet?
It's advisable to limit alcohol intake while using Verquvo 5 mg Tablet, as alcohol can affect blood pressure and overall health.
4. Are there any common side effects associated with Verquvo 5 mg Tablet?
Common side effects may include headache, dizziness, and nausea. If you experience severe side effects, contact your healthcare provider immediately.
5. How should I store Verquvo 5 mg Tablet?
Store Verquvo 5 mg Tablet at room temperature, away from moisture and heat. Keep it out of reach of children.
6. Can pregnant or breastfeeding women use Verquvo 5 mg Tablet?
Pregnant or breastfeeding women should consult their healthcare provider before using Verquvo 5 mg Tablet due to potential risks.
7. What should I do if I experience severe side effects?
If you experience severe side effects such as chest pain or difficulty breathing, seek immediate medical attention.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | E17345 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Bayer Pharmceuticals Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Verquvo 5 mg Tablet is a prescription medication primarily used in the management of pulmonary arterial hypertension (PAH). This condition is characterized by high blood pressure in the arteries that supply the lungs, leading to various complications and reduced quality of life. The active ingredient in Verquvo 5 mg Tablet is vericiguat, which belongs to a class of medications known as soluble guanylate cyclase (sGC) stimulators. By enhancing the sensitivity of sGC to nitric oxide, Verquvo 5 mg Tablet promotes vasodilation, thereby reducing pulmonary vascular resistance and improving exercise capacity in patients with PAH. The formulation is designed for oral administration, allowing for convenient dosing. Verquvo 5 mg Tablet is typically prescribed as part of a comprehensive treatment plan that may include other medications and lifestyle modifications aimed at managing PAH effectively. It is essential for patients to adhere to their prescribed regimen and consult healthcare professionals for any concerns regarding their treatment with Verquvo 5 mg Tablet. This medication has been shown to improve symptoms and overall functional capacity in individuals suffering from this debilitating condition, making it a vital component in the therapeutic arsenal against pulmonary arterial hypertension.
- Effective management of pulmonary arterial hypertension (PAH).
- Improves exercise capacity and quality of life in patients with PAH.
- Reduces pulmonary vascular resistance through vasodilation.
- Can be used in combination with other PAH therapies for enhanced efficacy.
- Helps alleviate symptoms associated with PAH, such as shortness of breath and fatigue.
- May contribute to improved hemodynamic parameters in patients.
- Supports long-term management strategies for chronic pulmonary conditions.
- Verquvo 5 mg Tablet stimulates soluble guanylate cyclase (sGC), enhancing its sensitivity to nitric oxide.
- This action leads to increased levels of cyclic guanosine monophosphate (cGMP), promoting relaxation of vascular smooth muscle.
- The resultant vasodilation decreases pulmonary arterial pressure.
- Improved blood flow reduces the workload on the heart.
- Enhances oxygen delivery to tissues, improving overall exercise capacity.
- Take Verquvo 5 mg Tablet orally, with or without food.
- The usual starting dose is 2.5 mg once daily, which may be increased to 5 mg based on tolerance and clinical response.
- Administer at the same time each day to maintain consistent blood levels.
- Do not crush or chew the tablet; swallow it whole with water.
- If a dose is missed, take it as soon as remembered unless it's close to the next scheduled dose; do not double up.
- Consult your healthcare provider for personalized dosage adjustments based on individual health status.
- Regular follow-up appointments are essential to monitor treatment efficacy and side effects.
- Maintain a balanced diet rich in fruits, vegetables, and whole grains to support overall cardiovascular health.
- Engage in regular physical activity as advised by your healthcare provider to improve exercise tolerance.
- Avoid smoking and limit alcohol consumption, as these can exacerbate PAH symptoms.
- Stay hydrated and manage stress through relaxation techniques such as yoga or meditation.
- Monitor your weight regularly and report any significant changes to your healthcare provider.
Side Effects
- Common side effects may include headache, dizziness, nausea, and fatigue.
- Some patients may experience low blood pressure, leading to symptoms like fainting or lightheadedness.
- Serious side effects can include allergic reactions, chest pain, or signs of liver problems such as jaundice.
- If you notice any unusual symptoms or side effects that persist or worsen, contact your healthcare provider promptly.
- Regular monitoring by your healthcare provider is recommended to ensure safety during treatment with Verquvo 5 mg Tablet.
Precautions and Warnings
- Do not use Verquvo 5 mg Tablet if you are allergic to vericiguat or any of its components.
- Patients with severe liver or kidney impairment should use this medication cautiously and under strict medical supervision.
- Avoid using Verquvo 5 mg Tablet in combination with nitrates or other sGC stimulators due to the risk of hypotension.
- Alcohol consumption should be limited while taking this medication due to potential interactions affecting blood pressure.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using this medication.
- Driving or operating heavy machinery may be unsafe if you experience dizziness or fatigue while taking Verquvo 5 mg Tablet; exercise caution.
Verquvo 5 mg Tablet may not be suitable for individuals with certain medical conditions or those taking specific medications. Always consult your healthcare provider before starting this medication.
2. What should I do if I miss a dose of Verquvo 5 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
3. Can I drink alcohol while taking Verquvo 5 mg Tablet?
It's advisable to limit alcohol intake while using Verquvo 5 mg Tablet, as alcohol can affect blood pressure and overall health.
4. Are there any common side effects associated with Verquvo 5 mg Tablet?
Common side effects may include headache, dizziness, and nausea. If you experience severe side effects, contact your healthcare provider immediately.
5. How should I store Verquvo 5 mg Tablet?
Store Verquvo 5 mg Tablet at room temperature, away from moisture and heat. Keep it out of reach of children.
6. Can pregnant or breastfeeding women use Verquvo 5 mg Tablet?
Pregnant or breastfeeding women should consult their healthcare provider before using Verquvo 5 mg Tablet due to potential risks.
7. What should I do if I experience severe side effects?
If you experience severe side effects such as chest pain or difficulty breathing, seek immediate medical attention.
Directions for Use
Storage and Disposal
| SKU | E17345 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Bayer Pharmceuticals Pvt Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account